Drug industry embraces new business strategies after tough year
Thursday, December 10, 2009 - 03:21
in Mathematics & Economics
As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical and Engineering News, ACS' weekly newsmagazine...